Drug Designing and Biomarkers
A biomarker is an attribute which will be studied as an indicator of pathogenic and biological operation alongside pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity within the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.
Drug Designing is an ingenious process to seek out new medication centered on the knowledge of biological target. Drug is most ordinarily a little molecule that inhibits or activates the function of a biomolecule, which successively outcomes during a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This sort of modelling is usually mentioned to as computer-aided drug design.
- Drug targets
- Ligand-based design
- Structure-based design
- Computer-aided drug design
- Scoring functions
Related Conference of Drug Designing and Biomarkers
Drug Designing and Biomarkers Conference Speakers
Recommended Sessions
- 3-D Structure Determination
- Advancements in structural Biology
- Biochemistry and Biophysics
- Computational Approach in Structural Biology
- Drug Designing and Biomarkers
- Frontiers in Structural Biology
- Gene Regulation and Cell Signaling
- Hybrid Approaches in Structure Prediction
- Molecular Biology
- Molecular Biology Techniques
- Molecular Modelling and Dynamics
- Proteomics and Genomics
- Sequencing Analysis
- Structural Bioinformatics
- Structural Biology
- Structural Biology Databases
- Structural Biology in Cancer Research
- Structural Enzymology
